Sep 23, 2025
Tylenol maker rebounds a day after Trump’s unfounded claims about its safety
Kenvue shares rebounded after Trump linked Tylenol to autism, claims disputed by the company and lacking new scientific evidence.
Aug 18, 2025
FDA’s new expert panels are rife with financial conflicts and fringe views
FDA Commissioner Marty Makary is using informal expert panels on antidepressants, menopause drugs and talc, raising conflict-of-interest concerns.